Belite Bio to Present at Two Medical Conferences
Belite Bio announced that it will present at two upcoming medical conferences. The company is developing novel therapeutics for degenerative retinal diseases.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
SAN DIEGO, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc NASDAQ:BLTE (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that its d…